Cotrifazid Safety and Efficacy Against Malaria

NCT00322907 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Clinical Malaria

Interventions

DRUG: Cotrifazid vs mefloquine or quinine+SP

Sponsor

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

Collaborators

[object Object]
[object Object]